| Xiao, Jun |
NCT05058040: A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules (GV-971) |
|
|
| Active, not recruiting | 4 | 2500 | RoW | Sodium Oligomannate Capsules | Green Valley (Shanghai) Pharmaceuticals Co., Ltd. | Alzheimer Disease | 01/25 | 04/25 | | |
| Active, not recruiting | 4 | 800 | RoW | Sodium Oligomannate Capsules (GV-971) | Green Valley (Shanghai) Pharmaceuticals Co., Ltd. | Alzheimer Disease | 01/25 | 06/25 | | |
NCT06707194: Effect and Safety of Benzathine Penicillin Combined With Etanercept on Spondyloarthritis |
|
|
| Not yet recruiting | 4 | 208 | RoW | Etanercept, Benzathine Penicillin, Placebo | Nanfang Hospital, Southern Medical University | Spondyloarthritis (SpA), Ankylosing Spondylitis (AS) | 09/25 | 09/26 | | |
EMBER-4, NCT05514054: A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer |
|
|
| Recruiting | 3 | 6000 | Europe, Canada, Japan, US, RoW | Imlunestrant, LY3484356, Tamoxifen, Anastrozole, Letrozole, Exemestane | Eli Lilly and Company | Breast Neoplasms | 10/27 | 03/32 | | |
NCT06180889: Factor XI inhibiTion for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty |
|
|
| Recruiting | 2 | 240 | RoW | Enoxaparin, KN060 Low, KN060 Middle, KN060 Hight | Suzhou Alphamab Co., Ltd. | Knee Arthroplasty, Total | 12/25 | 04/26 | | |
NCT05738694: Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell Carcinoma |
|
|
| Recruiting | 2 | 246 | RoW | Axitinib plus Toripalimab, nephrectomy | ZHOU FANGJIAN, Pfizer | Renal Cell Carcinoma, Neoadjuvant | 07/25 | 03/26 | | |
NCT06507462: A Diagnostic Prediction Model for Prostate Cancer in Patients With PI-RADS Score 3 |
|
|
| Recruiting | N/A | 500 | RoW | prostate biopsy | Anhui Provincial Hospital | Prostate Cancer | 10/24 | 12/24 | | |
NCT06467773: TSPO-PET/MRI in Surveillance of Neuroinflammation in the Central Nervous System |
|
|
| Not yet recruiting | N/A | 100 | RoW | Radiation: PET-MRI with [18F]-DPA-714 | Tongji Hospital, Wuhan Jianmin DAPENG Pharmaceutical Co., Ltd. | Central Nervous System Diseases | 06/29 | 12/29 | | |
FAVOR IV-QVAS, NCT03977129: Quantitative Flow Ratio (QFR) Guided Revascularization Strategy for Patients Undergoing Primary Valve Surgery With Comorbid Coronary Artery Disease |
|
|
| Active, not recruiting | N/A | 792 | RoW | QFR-guided strategy, CAG-guided strategy | Ruijin Hospital, Med-X Research Institute, Shanghai Jiao Tong University | Primary Valvular Heart Disease With Comorbid Coronary Artery Disease, Planned to Undergo Elective On-pump Valve Surgery Due to Primary Mitral and/or Aortic Valvular Heart Disease | 09/24 | 12/26 | | |
NCT06474507: Efficacy and Safety of Calculus Bovis Sativus (CBS) for Ischemic Cerebral Vascular Disease (CBSinICVD) |
|
|
| Recruiting | N/A | 230 | RoW | Calculus bovis sativus (CBS) | Tongji Hospital, Wuhan Jianmin DAPENG Pharmaceutical Co., Ltd. | Ischemic Cerebrovascular Disease, Acute Ischemic Stroke, Cerebral Small Vessel Diseases | 07/29 | 12/29 | | |
NCT06474520: Efficacy and Safety of Calculus Bovis Sativus (CBS) for Idiopathic Inflammatory Demyelinating Disease (CBSinIIDD) |
|
|
| Recruiting | N/A | 250 | RoW | Calculus bovis sativus (CBS) | Tongji Hospital, Wuhan Jianmin DAPENG Pharmaceutical Co., Ltd. | Idiopathic Inflammatory Demyelinating Disease, Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Acute Disseminated Encephalomyelitis | 07/29 | 12/29 | | |
5TbpMRI, NCT06612047: Comparison of 5.0T and 3.0T Biparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer |
|
|
| Not yet recruiting | N/A | 150 | NA | Prostate biopsy | Anhui Provincial Hospital | Prostate Cancer | 09/26 | 12/26 | | |
NCT06737588: The Addictive Diagnostic Value of Apparent Diffusion Coefficients to bpMRI in the Diagnosis of Prostate Cancer |
|
|
| Recruiting | N/A | 600 | RoW | | Anhui Provincial Hospital | Prostate Cancer | 12/26 | 03/27 | | |
NCT04847752: Study of Predictive Factors Related to Prognosis of Patients With Ischemic Stroke Due to Large-artery Atherosclerosis |
|
|
| Recruiting | N/A | 1000 | RoW | carotid artery stenting, CAS, carotid endarterectomy, CEA, Aspirin, ASP, Clopidogrel, plavix, Anticoagulant, warfarin, rivaroxaban, dabigatran, any other anticoagulant therapy, Statin, atorvastatin, rosuvastatin, any other statin drugs, PCSK9 inhibitor, Evolocumab, Alirocumab, any other PCSK9 inhibitors | Tongji Hospital | Ischemic Stroke, Large-Artery Atherosclerosis (Embolus/Thrombosis) | 12/26 | 12/28 | | |
| Zhang, Weikai |
| No trials found |
